Insider trades
Sumitomo Pharma, 10% Owner of Roivant Sciences ROIV, has filed 1 purchase and 1 sale on the open market. The latest trade was on 23/06/22.
Sumitomo Pharma
10% Owner
- Company
- Roivant Sciences ROIV
- First filing
- 23/03/06
- Trades
- 4 trades
- Buys / sales
- 1 / 1
- 12-month net buying
- No record
- Last trade
- 23/06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Roivant SciencesROIV | Open-market sale | 23/06/22 | 23/06/26 | 15,116,277 sh | $8.60 | $129,999,982.2 | −17.5% |
| Open-market buy | 23/03/10 | 23/03/10 | 51,599,200 sh | $27.00 | $1,393,178,400 | No record |